Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

INTRODUCTION: Due to the high cost and high failure rate of ascertaining amyloid positron emission tomography positivity (PET+) in patients with earlier stage Alzheimer’s disease (AD), an effective pre-screening tool for amyloid PET scans is needed. METHODS: Patients with mild cognitive impairment (...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Alzheimers Res Ther
Prif Awduron: Lin, Szu-Ying, Lin, Kun-Ju, Lin, Po-Chen, Huang, Chin-Chang, Chang, Chiung-Chih, Lee, Yi-Chung, Hsiao, Ing-Tsung, Yen, Tzu-Chen, Huang, Wen-Sheng, Yang, Bang-Hung, Wang, Pei-Ning
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2019
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6933740/
https://ncbi.nlm.nih.gov/pubmed/31881963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0566-0
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg